» Articles » PMID: 9894175

Determinants of Antepartum Human Immunodeficiency Virus Testing in a Non-Medicaid Obstetric Population

Overview
Publisher Wiley
Date 1999 Jan 23
PMID 9894175
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To determine voluntary human immunodeficiency virus (HIV) testing rates and factors influencing testing in a private obstetric practice.

Methods: Antepartum patients were offered HIV testing after completing a self-assessment questionnaire. Perceived risks and demographics were correlated with testing rates.

Results: Overall, 348/600 (58%) women consented to HIV testing. In a univariate analysis, patients with "any" perceived risk(s) were more likely to be tested. Single women and those with an at-risk partner(s) or a history of sexually transmitted disease (STD) were more likely to desire testing. These factors remained independently associated with voluntary testing in a multivariate regression model. No patients tested positive for HIV.

Conclusions: In our private obstetric practice, 26% of women perceived themselves at risk for HIV infection, and testing rates depended on the various risks identified. A history of STDs or an at-risk sexual partner were stronger predictors of voluntary testing than was marital status. Focused HIV counseling among pregnant women at relatively low risk for infection may be possible.

Citing Articles

Factors Associated with HIV Testing History among Pregnant Women and Their Partners in Georgia: The ANRS 12127 Prenahtest Trial.

Butsashvili M, Kajaia M, Kamkamidze G, Tchendjou P, du Lou A, Dabis F AIDS Res Treat. 2014; 2014:356090.

PMID: 25328692 PMC: 4195251. DOI: 10.1155/2014/356090.

References
1.
Barbacci M, Repke J, Chaisson R . Routine prenatal screening for HIV infection. Lancet. 1991; 337(8743):709-11. DOI: 10.1016/0140-6736(91)90286-x. View

2.
Lindsay M, Peterson H, Willis S, Slade B, Gramling J, Williams H . Incidence and prevalence of human immunodeficiency virus infection in a prenatal population undergoing routine voluntary human immunodeficiency virus screening, July 1987 to June 1990. Am J Obstet Gynecol. 1991; 165(4 Pt 1):961-4. DOI: 10.1016/0002-9378(91)90448-z. View

3.
Sperling R, Sacks H, Mayer L, Joyner M, Berkowitz R . Umbilical cord blood serosurvey for human immunodeficiency virus in parturient women in a voluntary hospital in New York City. Obstet Gynecol. 1989; 73(2):179-81. View

4.
Landesman S, Minkoff H, Holman S, McCalla S, Sijin O . Serosurvey of human immunodeficiency virus infection in parturients. Implications for human immunodeficiency virus testing programs of pregnant women. JAMA. 1987; 258(19):2701-3. View

5.
Connor E, Sperling R, Gelber R, Kiselev P, Scott G, OSullivan M . Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1994; 331(18):1173-80. DOI: 10.1056/NEJM199411033311801. View